Africa's mpox response is less than 10% funded, says Africa CDC

Africa has secured less than 10 percent of the estimated $245 million it needs to fight a surging mpox outbreak on the continent, a senior official from the Africa Centers for Disease Control and Prevention (Africa CDC) said on Wednesday.

The continent is under pressure to curb an outbreak of the potentially deadly infection that the World Health Organization (WHO) declared to be a global health emergency in mid-August, after a new strain began proliferating from Democratic Republic of Congo (DRC) to neighboring countries.

Africa CDC has pulled together a budget to determine the amount of money available for the mpox response and the resources it needs to mobilize.

"We've come to the first estimate of $245 million," Africa CDC Chief of Staff Ngashi Ngongo said at a WHO meeting in the Republic of Congo's capital Brazzaville.

DRC's government has committed $10 million to support the fight against the outbreak while the African Union has approved $10.4 million, Ngongo said.

Therefore, about $20 million is currently available for the response, he said, adding that these figures would be updated.

"The current gap where we stand today is about $224 million that we are looking for," he said.

Jean Kaseya, director general of Africa CDC, said during the meeting that the organisation was moving towards securing almost 1 million doses of mpox vaccine.

Those include 215,000 doses from vaccine maker Bavarian Nordic, 100,000 doses from France, almost 100,000 doses from Germany and about 500,000 doses from Spain.

There is no timeline yet on when the vaccines might reach the DRC, which is the most affected region by the virus.

Mpox, a viral infection that causes pus-filled lesions and flu-like symptoms, is usually mild but can kill.